Bulk Manufacturer of Controlled Substances Application: Halo Pharmaceutical, Inc.
| Published date | 06 October 2020 |
| Record Number | 2020-22076 |
| Section | Notices |
| Court | Drug Enforcement Administration,Justice Department |
Federal Register, Volume 85 Issue 194 (Tuesday, October 6, 2020)
[Federal Register Volume 85, Number 194 (Tuesday, October 6, 2020)]
[Notices]
[Page 63141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22076]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-727]
Bulk Manufacturer of Controlled Substances Application: Halo
Pharmaceutical, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Halo Pharmaceutical, Inc. has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before December 7,
2020. Such persons may also file a written request for a hearing on the
application on or before December 7, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 3, 2020, Halo Pharmaceutical Inc, 30 North
Jefferson Road, Whippany, New Jersey 07981, applied to be registered as
a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substances codes Schedule
------------------------------------------------------------------------
Dihydromorphine....................... 9145 I
Hydromorphone......................... 9150 II
------------------------------------------------------------------------
The company plans to manufacture Hydromorphone (9150) for
distribution to its customers. Dihydromorphine (9145) is an
intermediate in the manufacture of Hydromorphone and is not for
commercial distribution. No other activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22076 Filed 10-5-20; 8:45 am]
BILLING CODE 4410-09-P
